PLX

Protalix BioTherapeutics (PLX)

About Protalix BioTherapeutics (PLX)

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.

Details

Daily high
$2.04
Daily low
$1.95
Price at open
$2.00
52 Week High
$3.19
52 Week Low
$1.32
Market cap
161.1M
Dividend yield
0.00%
Volume
1.1M
Avg. volume
782,989
P/E ratio
10.95

Protalix BioTherapeutics News

Details

Daily high
$2.04
Daily low
$1.95
Price at open
$2.00
52 Week High
$3.19
52 Week Low
$1.32
Market cap
161.1M
Dividend yield
0.00%
Volume
1.1M
Avg. volume
782,989
P/E ratio
10.95